ADAR1 Capital Management’s NextCure NXTC Stock Holding History

ADAR1 Capital Management’s Portfolio NXTC Stock Details NXTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-9,834	Closed	-$54.3K	–	249
2025 Q2	$54.3K	Sell	9,834 -167	-2%	-$896	0.01%	189
2025 Q1	$57.6K	Hold	10,001	–	–	0.01%	177
2024 Q4	$92.5K	Hold	10,001	–	–	0.02%	182
2024 Q3	$164K	Buy	10,001 +2,583	+35%	+$47.5K	0.03%	170
2024 Q2	$142K	Buy	7,418 +3,833	+107%	+$74.5K	0.03%	157
2024 Q1	$95.9K	Sell	3,585 -1,450	-29%	-$25K	0.02%	153
2023 Q4	$68.9K	Buy	+5,035	New	+$73K	0.02%	104

Other funds holding NXTC

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Pfizer New York $170M AUM 191.09% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCC

Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

CPA

Cardiff Park Advisors Carlsbad, California $1.29B AUM 23.67% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ADAR1 Capital Management's NXTC Position: Q3 2025 in Review

ADAR1 Capital Management sold out of NextCure (NXTC) in Q3 2025, closing a stake of 9,834 shares — an estimated $54.3K sold.

ADAR1 Capital Management first reported a position in NXTC in Q4 2023 and held it in 7 quarters. The position peaked at $164K in Q3 2024. 17 funds tracked by Wall St. Rank hold NXTC as of Q3 2025.

ADAR1 Capital Management reported no remaining NextCure position as of Q3 2025 after selling out during the quarter.
ADAR1 Capital Management sold 9,834 NextCure shares in Q3 2025, an estimated $54.3K.
ADAR1 Capital Management first reported a position in NextCure in Q4 2023 and held it in 7 quarters.
ADAR1 Capital Management's NextCure position peaked at $164K in Q3 2024.
17 funds tracked by Wall St. Rank held NextCure as of Q3 2025.

Based on ADAR1 Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.